About DDB1- and CUL4-associated factor 4-like protein 2
DDB1- and CUL4-associated factor 4-like protein 2 (DCAF4L2) is a protein
from Homo sapiens identified by UniProt accession
Q8NA75, 395 residues long.
MolForge cross-references it against 0 known binders and
25 disease associations.
Target properties
| Protein name | DDB1- and CUL4-associated factor 4-like protein 2 |
| UniProt accession | Q8NA75 |
| Gene | DCAF4L2 |
| Organism | Homo sapiens |
| Length | 395 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (25)
Diseases linked to this target (Open Targets).
- cleft lip · score 0.37
- Cleft palate · score 0.35
- optic disc area measurement · score 0.30
- neurodegenerative disease · score 0.27
- Orofacial cleft · score 0.25
- progranulin measurement · score 0.24
- brain measurement · score 0.23
- cortical surface area measurement · score 0.21
- cortical thickness · score 0.21
- optic disc size measurement · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NA75-F1 | alphafold | PREDICTED | 85.12 | — |
Amino-acid sequence (395 residues)
MESKRPRLLE EADKQKKTVR VGLNAPSMLR KNQLGFLRFA NYCRIARELR VSCMQRKKVQ IHSWDPSSLA SDRFNRILAN TNTDQLFTVN QVEAGGSKYG IITMRGLTTP ELRVYPHKTL YVPNRKVNSM CWASLNHLDS HLLLCFVGLA DTPSCAVLLP ASLFIGSFPG MRRPGMLCSF QIPDAWSCAW SLSIHAYHSF STGLSQQVLL TNVVTGHQQS FGTSSDVLAQ QFAIMTPLLF NGCRSGEIFG IDLRCGNQGS GWKAICLSHD SAVTSLQILQ DGQFLVSSDM TGTIKLWDLR ATKCVTQYEG HVNNSAYLPV HVNEEEGVVA AVGQDCYTRI WSLRHGHLLT TIPSPYPASE NDIPSVAFSS RLGGFRGAPG LLMAVREDLY CFSYG
Explore DDB1- and CUL4-associated factor 4-like protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets